+ |
SIRT2 | up-regulates activity
deacetylation
|
PGAM2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266518 |
Lys100 |
GGLTGLNkAETAAKH |
Homo sapiens |
|
pmid |
sentence |
24786789 |
Here we report that PGAM is acetylated at lysine 100 (K100), an active site residue that is invariably conserved from bacteria, to yeast, plant, and mammals. K100 acetylation is detected in fly, mouse, and human cells and in multiple tissues and decreases PGAM2 activity. The cytosolic protein deacetylase sirtuin 2 (SIRT2) deacetylates and activates PGAM2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Glycolysis and Gluconeogenesis |
+ |
SIRT2 | up-regulates activity
deacetylation
|
PGAM1 |
0.284 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266517 |
Lys100 |
GGLTGLNkAETAAKH |
Homo sapiens |
|
pmid |
sentence |
24786789 |
Here we report that PGAM is acetylated at lysine 100 (K100), an active site residue that is invariably conserved from bacteria, to yeast, plant, and mammals. K100 acetylation is detected in fly, mouse, and human cells and in multiple tissues and decreases PGAM2 activity. The cytosolic protein deacetylase sirtuin 2 (SIRT2) deacetylates and activates PGAM2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Glycolysis and Gluconeogenesis |
+ |
SIRT2 | up-regulates quantity by stabilization
deacetylation
|
PCK1 |
0.437 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-267602 |
Lys594 |
KEVEDIEkYLEDQVN |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
21726808 |
Conversely, SIRT2 deacetylates and stabilizes PEPCK1.|Furthermore, coexpression of P300 increased acetylation levels of wild-type PEPCK1, but not PEPCK13K/R, indicating that P300 acts on these lysine residues of PEPCK1 |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-267599 |
Lys70 |
EGILRRLkKYDNCWL |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
21726808 |
Conversely, SIRT2 deacetylates and stabilizes PEPCK1.|Furthermore, coexpression of P300 increased acetylation levels of wild-type PEPCK1, but not PEPCK13K/R, indicating that P300 acts on these lysine residues of PEPCK1 |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-267601 |
Lys71 |
GILRRLKkYDNCWLA |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
21726808 |
Conversely, SIRT2 deacetylates and stabilizes PEPCK1.|Furthermore, coexpression of P300 increased acetylation levels of wild-type PEPCK1, but not PEPCK13K/R, indicating that P300 acts on these lysine residues of PEPCK1 |
|
Publications: |
3 |
Organism: |
Homo Sapiens |
Pathways: | Glycolysis and Gluconeogenesis |
+ |
CDK1 | down-regulates
phosphorylation
|
SIRT2 |
0.423 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-154681 |
Ser368 |
PNPSTSAsPKKSPPP |
Homo sapiens |
|
pmid |
sentence |
17488717 |
Here, we demonstrate that sirt2 is phosphorylated both in vitro and in vivo on serine 368 by the cell-cycle regulator, cyclin-dependent kinase 1. Overexpression of sirt2 mediates a delay in cellular proliferation that is dependent on serine 368 phosphorylation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CyclinE/CDK2 | down-regulates
phosphorylation
|
SIRT2 |
0.404 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-216725 |
Ser368 |
PNPSTSAsPKKSPPP |
Homo sapiens |
Neuron |
pmid |
sentence |
18332217 |
We define ser-331 as the site phosphorylated by cyclin e-cdk2, cyclin a-cdk2, and p35-cdk5 both in vitro and in cells. Importantly, phosphorylation at ser-331 inhibits the catalytic activity of sirt2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CDC14A |
dephosphorylation
|
SIRT2 |
0.433 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-248834 |
Ser368 |
PNPSTSAsPKKSPPP |
Homo sapiens |
|
pmid |
sentence |
17488717 |
Here, we demonstrate that SIRT2 is phosphorylated both in vitro and in vivo on serine 368 by the cell-cycle regulator, cyclin-dependent kinase 1, and dephosphorylated by the phosphatases CDC14A and CDC14B. Overexpression of SIRT2 mediates a delay in cellular proliferation that is dependent on serine 368 phosphorylation|Additionally, we found that SIRT2, like other Cdk1 targets, can be dephosphorylated by the phosphatases CDC14A and CDC14B. In contrast to a published report (8), we did not observe any degradation of SIRT2 by the 26 S proteasome in response to CDC14B overexpression|However, we cannot exclude the possibility that phosphorylation of serine 368 might affect the activity of SIRT2 on other unidentified acetylated substrates. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CDK2 | down-regulates
phosphorylation
|
SIRT2 |
0.404 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-177972 |
Ser368 |
PNPSTSAsPKKSPPP |
Homo sapiens |
|
pmid |
sentence |
18332217 |
We define ser-331 as the site phosphorylated by cyclin e-cdk2, cyclin a-cdk2, and p35-cdk5 both in vitro and in cells. Importantly, phosphorylation at ser-331 inhibits the catalytic activity of sirt2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CDC14B |
dephosphorylation
|
SIRT2 |
0.416 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-248338 |
Ser368 |
PNPSTSAsPKKSPPP |
Homo sapiens |
|
pmid |
sentence |
17488717 |
Here, we demonstrate that SIRT2 is phosphorylated both in vitro and in vivo on serine 368 by the cell-cycle regulator, cyclin-dependent kinase 1, and dephosphorylated by the phosphatases CDC14A and CDC14B. Overexpression of SIRT2 mediates a delay in cellular proliferation that is dependent on serine 368 phosphorylation|Additionally, we found that SIRT2, like other Cdk1 targets, can be dephosphorylated by the phosphatases CDC14A and CDC14B. In contrast to a published report (8), we did not observe any degradation of SIRT2 by the 26 S proteasome in response to CDC14B overexpression|However, we cannot exclude the possibility that phosphorylation of serine 368 might affect the activity of SIRT2 on other unidentified acetylated substrates. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SRC | down-regulates quantity by destabilization
phosphorylation
|
SIRT2 |
0.296 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263104 |
Tyr104 |
RSPSTGLyDNLEKYH |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
24996174 |
In this study, we investigated the potential regulation of SIRT2 function by c-Src. We found that the protein levels of SIRT2 were decreased by c-Src, and subsequently rescued by the addition of a Src specific inhibitor, SU6656, or by siRNA-mediated knockdown of c-Src. The c-Src interacts with and phosphorylates SIRT2 at Tyr104. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MYCN | up-regulates quantity by expression
transcriptional regulation
|
SIRT2 |
0.384 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255145 |
|
|
Homo sapiens |
Neuroblastoma Cell |
pmid |
sentence |
23175188 |
Here we demonstrated that the class III histone deacetylase SIRT2 was upregulated by N-Myc in neuroblastoma cells and by c-Myc in pancreatic cancer cells, and that SIRT2 enhanced N-Myc and c-Myc protein stability and promoted cancer cell proliferation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SIRT2 | down-regulates
deacetylation
|
MYOD1 |
0.385 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-104251 |
|
|
Homo sapiens |
|
pmid |
sentence |
12887892 |
Sir2-mediated deacetylation of myod can be expected to inhibit its transcriptional capabilities. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle, Skeletal Muscle |
+ |
MYC | up-regulates quantity by expression
transcriptional regulation
|
SIRT2 |
0.478 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255146 |
|
|
Homo sapiens |
Pancreatic Cancer Cell |
pmid |
sentence |
23175188 |
Here we demonstrated that the class III histone deacetylase SIRT2 was upregulated by N-Myc in neuroblastoma cells and by c-Myc in pancreatic cancer cells, and that SIRT2 enhanced N-Myc and c-Myc protein stability and promoted cancer cell proliferation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
ING1 | down-regulates activity
binding
|
SIRT2 |
0.463 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-254486 |
|
|
Homo sapiens |
|
pmid |
sentence |
14522900 |
We found that p33(ING1b) physically interacts with hSIR2, reverses its ability to induce the AFP promoter, and induces acetylation of p53 residues at Lys(373) and/or Lys(382). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SIRT2 | up-regulates quantity by stabilization
|
MYCN |
0.384 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255147 |
|
|
Homo sapiens |
|
pmid |
sentence |
23175188 |
Here we demonstrated that the class III histone deacetylase SIRT2 was upregulated by N-Myc in neuroblastoma cells and by c-Myc in pancreatic cancer cells, and that SIRT2 enhanced N-Myc and c-Myc protein stability and promoted cancer cell proliferation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SIRT2 | down-regulates
binding
|
KAT2B |
0.546 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-104248 |
|
|
Homo sapiens |
|
pmid |
sentence |
12887892 |
Sir2 forms a complex with the acetyltransferase pcaf and myod and, when overexpressed, retards muscle differentiation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle, Skeletal Muscle |
+ |
SIRT2 | up-regulates quantity by expression
transcriptional regulation
|
AFP |
0.26 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-254487 |
|
|
Homo sapiens |
Hep-G2 Cell |
pmid |
sentence |
14522900 |
In this study, we found that a subset of ING family members strongly repressed human alpha-fetoprotein (AFP) promoter activity but stimulated the p21(WAF1) promoter in parallel experiments in the same cell type, similar to the effects of p53. Both ING1 and p53 were able to suppress AFP transcription and cause p21 induction; hSIR2, a negative regulator of the p53 protein, showed the opposite effects on the AFP promoter and, like HDAC1, repressed p21 promoter activity. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SIRT2 | down-regulates quantity by repression
transcriptional regulation
|
NEDD4 |
0.265 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255144 |
|
|
Homo sapiens |
|
pmid |
sentence |
23175188 |
SIRT2 repressed NEDD4 gene expression by directly binding to the NEDD4 gene core promoter and deacetylating histone H4 lysine 16. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SIRT2 | up-regulates activity
deacetylation
|
PGAM |
0.284 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266519 |
|
|
Homo sapiens |
|
pmid |
sentence |
24786789 |
Here we report that PGAM is acetylated at lysine 100 (K100), an active site residue that is invariably conserved from bacteria, to yeast, plant, and mammals. K100 acetylation is detected in fly, mouse, and human cells and in multiple tissues and decreases PGAM2 activity. The cytosolic protein deacetylase sirtuin 2 (SIRT2) deacetylates and activates PGAM2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Glycolysis and Gluconeogenesis |
+ |
SIRT2 | up-regulates quantity by stabilization
|
MYC |
0.478 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255148 |
|
|
Homo sapiens |
|
pmid |
sentence |
23175188 |
Here we demonstrated that the class III histone deacetylase SIRT2 was upregulated by N-Myc in neuroblastoma cells and by c-Myc in pancreatic cancer cells, and that SIRT2 enhanced N-Myc and c-Myc protein stability and promoted cancer cell proliferation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
SIRT2 | down-regulates quantity by repression
transcriptional regulation
|
CDKN1A |
0.315 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-254481 |
|
|
Homo sapiens |
Hep-G2 Cell |
pmid |
sentence |
14522900 |
In this study, we found that a subset of ING family members strongly repressed human alpha-fetoprotein (AFP) promoter activity but stimulated the p21(WAF1) promoter in parallel experiments in the same cell type, similar to the effects of p53. Both ING1 and p53 were able to suppress AFP transcription and cause p21 induction; hSIR2, a negative regulator of the p53 protein, showed the opposite effects on the AFP promoter and, like HDAC1, repressed p21 promoter activity. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |